An increasing volume of both EG column inches and commercial investor attention is being commanded by the life science sector - underpinned by a variety of growth factors and significant increases in both public and private sector funding.

EG last week revealed our own research which looked beyond the traditional 'Golden Triangle' heartland of life sciences for alternative areas which appear best-placed to benefit from the expansion of domestic industry.

Graham Shone is joined on this edition of 'No Filter' by Deputy Legal Editor Jess Harrold to discuss the research published last week, how it came about, and what it might mean for some of those locations highlighted.